HomeInsightsStock Comparison

Aarti Drugs Ltd vs Fdc Ltd Stock Comparison

Aarti Drugs Ltd vs Fdc Ltd Stock Comparison

Last Updated on: May 13, 2025

Key Highlights

  • The Latest Trading Price of Aarti Drugs Ltd is ₹ 440.25 as of 13 May 09:40.
  • The P/E Ratio of Aarti Drugs Ltd changed from 8.3 on March 2020 to 23.3 on March 2024 . This represents a CAGR of 22.93% over 5 yearsThe P/E Ratio of FDC Ltd changed from 14 on March 2020 to 22.6 on March 2024 . This represents a CAGR of 10.05% over 5 years.
  • The Market Cap of Aarti Drugs Ltd changed from ₹ 1178 crore on March 2020 to ₹ 3988 crore on March 2024 . This represents a CAGR of 27.61% over 5 yearsThe Market Cap of FDC Ltd changed from ₹ 3350 crore on March 2020 to ₹ 6912 crore on March 2024 . This represents a CAGR of 15.59% over 5 years.
  • The revenue of Aarti Drugs Ltd for the Mar '25 is ₹ 678.63 crore as compare to the Dec '24 revenue of ₹ 568.5 crore. This represent the growth of 19.37% The revenue of FDC Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 482.94 crore. This represent the decline of -100%.
  • The ebitda of Aarti Drugs Ltd for the Mar '25 is ₹ 95.2 crore as compare to the Dec '24 ebitda of ₹ 73.62 crore. This represent the growth of 29.31% The ebitda of FDC Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 65.48 crore. This represent the decline of -100%.
  • The net profit of Aarti Drugs Ltd changed from ₹ 47.97 crore to ₹ 62.77 crore over 8 quarters. This represents a CAGR of 14.39% The net profit of FDC Ltd changed from ₹ 109.81 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Aarti Drugs Ltd changed from 3.43 % on March 2020 to 6.48 % on March 2024 . This represents a CAGR of 13.57% over 5 yearsThe Dividend Payout of FDC Ltd changed from 5.54 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aarti Drugs Ltd

  • Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
  • The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
  • With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
  • It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
  • It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).

About FDC Ltd

  • FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
  • The Company is a prominent player in the Indian pharmaceutical industry, renowned for its expertise in developing specialised formulations.
  • It leads the market in sectors such as Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies.
  • It has established a global footprint in both domestic and international market, standing as a beacon of excellence in pharmaceutical and consumer healthcare industry. Promoted as a partnership firm in 1936 by the Late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods, FDC Limited was established on September 23, 1940.

Aarti Drugs Ltd News Hub

News

Aarti Drugs to convene board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 6 May 2025. Po...

Read more

30 Apr 2025 11:38

News

Aarti Drugs receives affirmation in credit ratings from ICRA

Aarti Drugs has received reaffirmation in credit rating at ICRA AA-; Stable/ ICRA A1+ for ...

Read more

31 Jan 2025 19:10

News

Aarti Drugs gains as PAT rises to Rs 37 cr in Q3; declares dividend of Re 1/sh

Revenue from operations declined 6.44% to Rs 568.50 crore in third quarter of FY25 as comp...

Read more

30 Jan 2025 12:14

News

Board of Aarti Drugs recommends Interim Dividend

Aarti Drugs announced that the Board of Directors of the Company at its meeting held on 29...

Read more

29 Jan 2025 17:03

News

Aarti Drugs to conduct board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 29 January 202...

Read more

23 Jan 2025 11:25

News

Aarti Drugs's receives Establishment Inspection Report for API manufacturing unit

Aarti Drugs has received Establishment Inspection Report (EIR) from USFDA concluding the i...

Read more

24 Dec 2024 15:12

FDC Ltd News Hub

News

FDC to declare Quarterly Results

FDC will hold a meeting of the Board of Directors of the Company on 12 February 2025. Powe...

Read more

08 Feb 2025 11:03

News

FDC gets USFDA nod for anti-bacterial drug

The announcement was made at the fag end of market hours yesterday. Cefixime is used to tr...

Read more

19 Dec 2024 10:47

News

Board of FDC recommends first interim dividend

FDC announced that the Board of Directors of the Company at its meeting held on 6 November...

Read more

07 Nov 2024 15:15

News

FDC schedules board meeting

FDC will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powere...

Read more

29 Oct 2024 15:20

News

FDC Ltd leads gainers in 'A' group

Kaynes Technology India Ltd, Engineers India Ltd, Mrs Bectors Food Specialities Ltd and Va...

Read more

12 Sep 2024 12:00

News

FDC schedules AGM

FDC announced that the Annual General Meeting (AGM) of the company will be held on 26 Sept...

Read more

10 Sep 2024 10:33

SWOT Analysis Of FDC Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of Aarti Drugs Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for FDC Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Aarti Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aarti Drugs Ltd and FDC Ltd

Which company has a larger market capitalization, Aarti Drugs Ltd or FDC Ltd?

Market cap of Aarti Drugs Ltd is 3,935 Cr while Market cap of FDC Ltd is 7,082 Cr

What are the key factors driving the stock performance of Aarti Drugs Ltd and FDC Ltd?

The stock performance of Aarti Drugs Ltd and FDC Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Drugs Ltd and FDC Ltd?

As of May 13, 2025, the Aarti Drugs Ltd stock price is INR ₹428.1. On the other hand, FDC Ltd stock price is INR ₹435.0.

How do dividend payouts of Aarti Drugs Ltd and FDC Ltd compare?

To compare the dividend payouts of Aarti Drugs Ltd and FDC Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions